文档介绍：盐酸贝那普利(洛汀新)治疗心房颤动的临床研究
王洪静1 周雪艳2
(,黑龙江大庆 163453
大学中日联谊医院心内科,吉林长春 130031)
[摘要] 目的:探讨应用血管紧张素转换酶抑制剂治疗房颤的临床意义;方法:60例房颤患者随机分为2组,1组常规治疗设为对照组,1组在给予常规治疗的基础上加用ACEI类药物(洛汀新)设为治疗组,观测两组房颤患者的转复成功率、房颤复发率、左心功能EF%、左房大小,血管紧张素II水平(AngII),心电图ST段改变,随访6个月,结果:治疗组较对照组AngII浓度降低,房颤转复成功率高,复发率低、左心房缩小,半年后发生心功能不全的比例均较对照组低。结论:房颤患者早期应用血管紧张素转换酶抑制剂,可能改善房颤的转律效果及抑制心房重构,改善心功能。
[关键词] 心房颤动肾素-血管紧张素-醛固酮系统血管紧张素转换酶抑制剂盐酸贝那普利
[中图分类号] [文献标识码] B
The clinical research of Benazepril hydrochloride(lotensin) to treat atrial fibrillation
WANG Hong-jing1,ZHOU Xue-yan2
( of Cadre Ward,Longnan hospital, Daqing163453,China;-r China-Japan Union Hospital,Jilin University,Changchun 130031,China)
Abstract: Objective To discuss vascular tension pigment conversion enzyme inhibitor treatment atrial fibrillation of clinical significance. Method: 60 cases atrial fibrillation patients random is divided into 2 group, 1 Group General treatment set for controlled group,
1 group in regular treatment on the basis of the additional application of ACEI drug (lotensin) is set to the treatment group,observation two group atrial fibrillation patients of cardioversion ess rate, and atrial fibrillation recurrence rate, and left heart function EF%, and left atrial size, vascular tension pigment II level (AngII), ECG ST segment change, follow-up 6 : Treatment pared w